Colgate-Palmolive (CL)

• Market cap: $72.5B
• 1 day: 0.15%
• 5 days: 2.33%
• 1 month: -5.13%
• 3 months: -11.78%
• 6 months: -10.77%
• Year to date: -2.05%
• 1 year: 9.55%
• 5 years: 24.60%
• 10 years: 28.61%
• Sector: Materials
• Industry: Perfumes, Cosmetics & Other Toilet Preparations

About: Since its founding in 1806, Colgate-Palmolive has grown to become a leading player in the household and personal care arena. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and homecare products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one fifth of sales), which primarily sells its products through veterinarians and specialty pet retailers.

Employees: 34,000

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

142% more first-time investments, than exits

New positions opened: 184 | Existing positions closed: 76

5% more funds holding

Funds holding: 1,793 [Q2] → 1,876 (+83) [Q3]

3% more capital invested

Capital invested by funds: $66.9B [Q2] → $68.9B (+$2.02B) [Q3]

1% less call options, than puts

Call options by funds: $475M | Put options by funds: $479M

5% less repeat investments, than reductions

Existing positions increased: 647 | Existing positions reduced: 680

2.98% less ownership

Funds ownership: 84.05% [Q2] → 81.07% (-2.98%) [Q3]

10% less funds holding in top 10

Funds holding in top 10: 10 [Q2] → 9 (-1) [Q3]

Research analyst outlook

7 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $83 6% downside
• Avg. target: $97 10% upside
• High target: $112 26% upside

7 analyst ratings

• positive: 4 57%
• neutral: 2 29%
• negative: 1 14%

Stifel Mark Astrachan 43% 1-year accuracy 13 / 30 met price target	7% upside $95	Hold Maintained	17 Jan 2025
Barclays Lauren Lieberman 36% 1-year accuracy 32 / 88 met price target	6% downside $83	Equal-Weight Maintained	17 Jan 2025
UBS Peter Grom 41% 1-year accuracy 9 / 22 met price target	17% upside $104	Buy Maintained	16 Jan 2025
JP Morgan Andrea Teixeira 39% 1-year accuracy 21 / 54 met price target	16% upside $103	Overweight Maintained	16 Jan 2025
TD Cowen Robert Moskow 50% 1-year accuracy 30 / 60 met price target	13% upside $100	Buy Maintained	8 Jan 2025